Literature DB >> 28523137

Complex multimodality central airway management of aspergillus pseudomembranous tracheobronchitis.

Samjot Singh Dhillon1,2, Marwan Saoud3, Kassem Harris4.   

Abstract

A 69-year-old woman developed central airway obstruction due to invasive Aspergillus infection resulting in pseudomembranous tracheobronchitis (PTB). Several challenges were encountered in the airway management of this patient including her having relatively smaller airways which were more prone to obstruction by pseudomembranes and made airway interventions difficult. The patient had clinical deterioration in spite of antifungal therapy and bronchoscopic debridement. The multimodality airway techniques included the use of smaller biliary balloons for dilatation, using a hybrid stent to slowly dilate and maintain patency of right main stem and finally the insertion of right secondary carina peripheral Y stent, which resulted in clinical improvement and allowed time for antifungal therapy to take effect. To the best of our knowledge, the use of a peripheral Y stent has never been described in the setting of PTB.

Entities:  

Keywords:  Aspergillus; airway stent; bronchoscopy; central airway obstruction; pseudomonas tracheobronchitis

Year:  2017        PMID: 28523137      PMCID: PMC5418247          DOI: 10.21037/jtd.2017.03.68

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

Review 1.  Diagnosis and treatment of pulmonary aspergillosis syndromes.

Authors:  Karen C Patterson; Mary E Strek
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

2.  Outcome of TiNi stent treatments in symptomatic central airway stenoses caused by Aspergillus fumigatus infections after lung transplantation.

Authors:  B X Xie; Y M Zhu; C Chen; D P Zhao; C L Yang; J A Ding; G N Jiang
Journal:  Transplant Proc       Date:  2013 Jul-Aug       Impact factor: 1.066

3.  Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome.

Authors:  Selçuk Tasci; Axel Glasmacher; Silvia Lentini; Klaus Tschubel; Santiago Ewig; Ernst Molitor; Tilman Sauerbruch; Berndt Lüderitz; Christian Rabe
Journal:  Mycoses       Date:  2006-01       Impact factor: 4.377

4.  Personalized bronchial stent therapy.

Authors:  Kassem Harris; Samjot S Dhillon; Abdul Hamid Alraiyes
Journal:  Ann Am Thorac Soc       Date:  2015-03

5.  Pseudomembranous Aspergillus tracheobronchitis: a potential for high mortality in low-risk patients.

Authors:  Yuping Li; Fangyou Yu; Chris Parsons; Chengshui Chen; Min Ye; Junru Ye; Yin Zhou; Chang Cai
Journal:  Am J Med Sci       Date:  2013-11       Impact factor: 2.378

Review 6.  Endobronchial fungal disease: an under-recognized entity.

Authors:  Demet Karnak; Robin K Avery; Thomas R Gildea; Debasis Sahoo; Atul C Mehta
Journal:  Respiration       Date:  2006-07-20       Impact factor: 3.580

7.  Bronchomediastinal fistula caused by endobronchial aspergilloma.

Authors:  A Christine Argento; Cameron R Wolfe; Momen M Wahidi; Scott L Shofer; Kamran Mahmood
Journal:  Ann Am Thorac Soc       Date:  2015-01

8.  Silicone y-stent placement on the carina between bronchus to the right upper lobe and bronchus intermedius.

Authors:  Masahide Oki; Hideo Saka; Chiyoe Kitagawa; Yoshihito Kogure
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

9.  Pseudomembranous aspergillus tracheobronchitis superimposed on post-tuberculosis tracheal stenosis.

Authors:  Prapaporn Pornsuriyasak; Septimiu Murgu; Henri Colt
Journal:  Respirology       Date:  2009-01       Impact factor: 6.424

10.  Acute airway obstruction and necrotizing tracheobronchitis from invasive mycosis.

Authors:  J B Putnam; C Dignani; R C Mehra; E J Anaisse; R C Morice; H I Libshitz
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.